Which is better, PME.AX or SANOFICONR.BO?

On the Buffett-Fit framework, Pro Medicus Limited (PME.AX) currently grades higher than SANOFICONR.BO — 78/100 (B grade) vs 78/100 (B). That said, "better" depends on which framework you trust — PME.AX wins on Benjamin Graham, Philip Fisher, Peter Lynch, Charlie Munger, and Terry Smith; SANOFICONR.BO wins on Joel Greenblatt. The full pillar breakdown is on this page.

Should I buy PME.AX or SANOFICONR.BO?

This page is an educational comparison, not investment advice. Both PME.AX and SANOFICONR.BO are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is PME.AX better than SANOFICONR.BO for value investing?

The two are close on the headline Buffett-Fit score (78/100 vs 78/100), so "better for value investing" depends on which pillar you weight most. The five Buffett pillars + six other frameworks are broken down side-by-side on this page so you can pick the one that fits your style.

What's the difference between PME.AX and SANOFICONR.BO on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). PME.AX currently scores 78/100 (B grade); SANOFICONR.BO scores 78/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, PME.AX or SANOFICONR.BO?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. PME.AX and SANOFICONR.BO are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, PME.AX or SANOFICONR.BO?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are PME.AX and SANOFICONR.BO both Healthcare stocks?

Yes — both Pro Medicus Limited (PME.AX) and Sanofi Consumer Healthcare India Limited (SANOFICONR.BO) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this PME.AX vs SANOFICONR.BO comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Pro Medicus Limited

PME.AX$18.81BHealthcare Market cap, Sector

Sanofi Consumer Healthcare India Limited

SANOFICONR.BO$105.09BHealthcare Market cap, Sector

Overall winner

Pro Medicus Limited

PME.AX 51 SANOFICONR.BO

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

Fit scores by strategy

PME.AX5wins

1winsSANOFICONR.BO

Warren Buffett

78B

B78

Benjamin Graham

90A

A89

Philip Fisher

98A

B83

Peter Lynch

100A

B77

Joel Greenblatt

84B

A91

Charlie Munger

91A

A86

Terry Smith

96A

A85

Side-by-side metrics

Metric	PME.AX	SANOFICONR.BO
Market cap	$18.81B	$105.09B Winner
P/E (TTM)	147.6x	44.0x Winner
EV/EBIT	106.8x	31.7x Winner
ROIC (TTM)	42.56%	59.15% Winner
Gross margin	Winner: 99.85%	68.13%
Net margin	Winner: 54.12%	27.35%
Revenue CAGR 5y	Winner: 31.61%	27.01%
EPS CAGR 5y	Winner: 37.34%	20.67%
Debt / Equity	Winner: 0.0x	0.1x
Dividend yield	-	-

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

PME.AX leads on

Debt / Equity0.0xvs 0.1x+86%
Net margin54.12%vs 27.35%+49%
EPS CAGR 5y37.34%vs 20.67%+45%
Gross margin99.85%vs 68.13%+32%

SANOFICONR.BO leads on

Market cap$105.09Bvs $18.81B+82%
EV/EBIT31.7xvs 106.8x+70%
P/E (TTM)44.0xvs 147.6x+70%
ROIC (TTM)59.15%vs 42.56%+28%

More like PME.AX

PME.AX vs JSLL.BO PME.AX vs JSLL.NS PME.AX vs 4728.TWO PME.AX vs CAMX.ST

More like SANOFICONR.BO

SANOFICONR.BO vs JSLL.BO SANOFICONR.BO vs JSLL.NS SANOFICONR.BO vs 4728.TWO SANOFICONR.BO vs CAMX.ST

Read the full Buffett-Brain analysis for PME.AX Read the full Buffett-Brain analysis for SANOFICONR.BO

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Side-by-side metrics

Metric	PME.AX	SANOFICONR.BO
Market cap	$18.81B	$105.09B Winner
P/E (TTM)	147.6x	44.0x Winner
EV/EBIT	106.8x	31.7x Winner
ROIC (TTM)	42.56%	59.15% Winner
Gross margin	Winner: 99.85%	68.13%
Net margin	Winner: 54.12%	27.35%
Revenue CAGR 5y	Winner: 31.61%	27.01%
EPS CAGR 5y	Winner: 37.34%	20.67%
Debt / Equity	Winner: 0.0x	0.1x
Dividend yield	-	-

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

PME.AX leads on

Debt / Equity0.0xvs 0.1x+86%
Net margin54.12%vs 27.35%+49%
EPS CAGR 5y37.34%vs 20.67%+45%
Gross margin99.85%vs 68.13%+32%

SANOFICONR.BO leads on

Market cap$105.09Bvs $18.81B+82%
EV/EBIT31.7xvs 106.8x+70%
P/E (TTM)44.0xvs 147.6x+70%
ROIC (TTM)59.15%vs 42.56%+28%